Literature DB >> 15184414

Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland.

Anna Sajduda1, Anna Brzostek, Marta Poplawska, Ewa Augustynowicz-Kopec, Zofia Zwolska, Stefan Niemann, Jaroslaw Dziadek, Doris Hillemann.   

Abstract

A total of 105 rifampin (RMP)- and/or isoniazid (INH)-resistant strains of Mycobacterium tuberculosis isolated from different parts of Poland in 2000 were screened for mutations associated with resistance to these drugs by two molecular methods, namely sequence analysis and real-time PCR technology. Three loci associated with drug resistance were selected for characterization: they were rpoB (RMP), katG, and the regulatory region of inhA (INH). Nineteen different mutations were identified in 64 RMP-resistant strains, and five new alleles were described. The most common point mutations were in codons 531 (41%), 516 (16%), and 526 (9%) of the rpoB gene. Mutations were not found in two (3%) of the isolates. In the case of resistance to INH, six different mutations in the katG gene of 83 resistant strains were detected. Fifty-seven (69%) isolates exhibited nucleotide substitutions at codon 315. One strain harbored a mutation affecting codon 279 (Gly279Thr). Twelve of 26 INH-resistant strains with the wild-type codon 315 (14.5% of all strains tested) had the mutation -15C-->T in the regulatory region of inhA. A full correlation between the DNA sequence analysis and real-time PCR data was obtained. We conclude that the real-time PCR method is fast and reliable for the detection of RMP and INH resistance-associated mutations in M. tuberculosis clinical isolates.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15184414      PMCID: PMC427864          DOI: 10.1128/JCM.42.6.2425-2431.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Mutations in the beginning of the rpoB gene can induce resistance to rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis.

Authors:  M Heep; U Rieger; D Beck; N Lehn
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

Review 2.  Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.

Authors:  S Ramaswamy; J M Musser
Journal:  Tuber Lung Dis       Date:  1998

Review 3.  The genetics and biochemistry of isoniazid resistance in mycobacterium tuberculosis.

Authors:  R A Slayden; C E Barry
Journal:  Microbes Infect       Date:  2000-05       Impact factor: 2.700

4.  Detection of rpoB mutations in Mycobacterium tuberculosis by biprobe analysis.

Authors:  K J Edwards; L A Metherell; M Yates; N A Saunders
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

5.  Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay.

Authors:  Z Bártfai; A Somoskövi; C Ködmön; N Szabó; E Puskás; L Kosztolányi; E Faragó; J Mester; L M Parsons; M Salfinger
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

6.  Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons.

Authors:  H H El-Hajj; S A Marras; S Tyagi; F R Kramer; D Alland
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

7.  Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in North India.

Authors:  Noman Siddiqi; Mohammed Shamim; Seema Hussain; Rakesh Kumar Choudhary; Niyaz Ahmed; Sharmistha Banerjee; G R Savithri; Mahfooz Alam; Niteen Pathak; Amol Amin; Mohammed Hanief; V M Katoch; S K Sharma; Seyed E Hasnain
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

8.  Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates.

Authors:  M Heep; B Brandstätter; U Rieger; N Lehn; E Richter; S Rüsch-Gerdes; S Niemann
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

9.  Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosis.

Authors:  M J Torres; A Criado; J C Palomares; J Aznar
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

10.  Mutations in the rpoB and katG genes leading to drug resistance in Mycobacterium tuberculosis in Latvia.

Authors:  T Tracevska; I Jansone; L Broka; O Marga; V Baumanis
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

View more
  36 in total

1.  Disequilibrium in distribution of resistance mutations among Mycobacterium tuberculosis Beijing and non-Beijing strains isolated from patients in Germany.

Authors:  Doris Hillemann; Tanja Kubica; Sabine Rüsch-Gerdes; Stefan Niemann
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

2.  Occurrence of rpoB mutations in isoniazid-resistant but rifampin-susceptible Mycobacterium tuberculosis isolates from Germany.

Authors:  Sönke Andres; Doris Hillemann; Sabine Rüsch-Gerdes; Elvira Richter
Journal:  Antimicrob Agents Chemother       Date:  2013-10-21       Impact factor: 5.191

3.  Visual detection of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis strains by use of an asymmetrically split peroxidase DNAzyme.

Authors:  Minggang Deng; Shuo Feng; Fengling Luo; Shaoru Wang; Xiaoming Sun; Xiang Zhou; Xiao-Lian Zhang
Journal:  J Clin Microbiol       Date:  2012-08-08       Impact factor: 5.948

4.  Characterization of Mutations Conferring Resistance to Rifampin in Mycobacterium tuberculosis Clinical Strains.

Authors:  Tomasz Jagielski; Zofia Bakuła; Anna Brzostek; Alina Minias; Radosław Stachowiak; Joanna Kalita; Agnieszka Napiórkowska; Ewa Augustynowicz-Kopeć; Anna Żaczek; Edita Vasiliauskiene; Jacek Bielecki; Jarosław Dziadek
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

5.  Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates.

Authors:  Doris Hillemann; Michael Weizenegger; Tanja Kubica; Elvira Richter; Stefan Niemann
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

6.  First isolation of Mycobacterium spp. in Mullus spp. in Turkey.

Authors:  P Sevim; S Ozer; F Rad
Journal:  Iran J Vet Res       Date:  2015       Impact factor: 1.376

7.  Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated in Nepal.

Authors:  Ajay Poudel; Chie Nakajima; Yukari Fukushima; Haruka Suzuki; Basu Dev Pandey; Bhagwan Maharjan; Yasuhiko Suzuki
Journal:  Antimicrob Agents Chemother       Date:  2012-03-26       Impact factor: 5.191

8.  In vitro activity of novel rifamycins against rifamycin-resistant Staphylococcus aureus.

Authors:  Christopher K Murphy; Steve Mullin; Marcia S Osburne; John van Duzer; Jim Siedlecki; Xiang Yu; Kathy Kerstein; Michael Cynamon; David M Rothstein
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

9.  Genetic evaluation of relationship between mutations in rpoB and resistance of Mycobacterium tuberculosis to rifampin.

Authors:  Anna Zaczek; Anna Brzostek; Ewa Augustynowicz-Kopec; Zofia Zwolska; Jaroslaw Dziadek
Journal:  BMC Microbiol       Date:  2009-01-15       Impact factor: 3.605

10.  Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance.

Authors:  Indra L Bergval; Anja R J Schuitema; Paul R Klatser; Richard M Anthony
Journal:  J Antimicrob Chemother       Date:  2009-07-04       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.